DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Sands BE, Kozarek R, Spainhour J et al.
Safety and tolerability of concurrent Natalizumab treatment for patients with Crohn´s disease not in remission while receiving infliximab.
Inflamm Bowel Dis
13: 2-11
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.